WIKIMEDIA, CARINE06Nearly four years ago, patients who participated in clinical trials led by oncologist Anil Potti—formerly of Duke University—and the families of patients who had died sued the researcher and the school for “fraudulent and negligent behavior” after Potti admitted to fabricating statistical analyses of chemotherapy’s effects on breast cancer, among other acts of misconduct. That suit has now been settled, Retraction Watch reported last week (May 1).
Thomas Henson, counsel for the plaintiffs, told Retraction Watch: “Our clients and Duke University Health System have resolved and settled all claims against the current defendants arising out of the genomics-based clinical trials for cancer treatment. The specific terms of the settlement are confidential, by mutual agreement of the parties.”
.jpg){kind=link}